Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > PHAR Pharming Group > Company Executives
PHAR Pharming Group
Post Mkt Price
NamePositionSalaryService DateEducationAgeGenderUpdated
Dr. Sijmen (Simon) de Vries, M.D.Chief Executive Officer and Director2.46M----62male04/06/2022
Mr. Jeroen WakkermanChief Financial Officer52.00K----52male04/06/2022
Ms. Mireille SandersChief Operations Officer------53female04/06/2022
Mr. Stephen ToorChief Commercial Officer and General Manager, Americas------50male04/06/2022
Mr. Anurag RelanChief Medical Officer------49male04/06/2022
Dr. Robert FriesenChief Scientific Officer------57male04/06/2022
Mr. Ruud van OutersterpChief Ethics and Compliance Officer and Company Secretary------57male04/06/2022
Mr. Paul SekhriChairman of the Board132.00K----63male04/06/2022
Ms. Deborah A. JornVice Chairman of the Board106.00K----63female04/06/2022
Dr. Mark J. Pykett,PhD,V.M.D.Director93.00K----58male04/06/2022
Ms. Barbara YanniDirector96.00K----67female04/06/2022
Mr. Steven BaertDirector69.00K----47male04/06/2022
Mr. Leonard KruimerIndependent Director71.00K----55male04/06/2022
Ms. Jabine van der MeijsIndependent Director71.00K----55female04/06/2022
Company Overview More
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.
CEO: Dr. Sijmen (Simon) de Vries, M.D.
Market: NASDAQ
Futu Hot List
SymbolLatest price%Chg